Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy

Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy

Coronavirus disease 2019 (COVID-19), the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which counts more than 650 million cases and more than 6.6 million of deaths worldwide, affects the respiratory system with typical symptoms such as fever, cough, sore throat, ac...

Full description

Bibliographic Details
Main Authors: Eleonora Russo, Simona Corrao, Francesca Di Gaudio, Giusi Alberti, Martin Caprnda, Peter Kubatka, Peter Kruzliak, Vitale Miceli, Pier Giulio Conaldi, Cesario Venturina Borlongan, Giampiero La Rocca
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cells
Subjects:
COVID-19
SARS-CoV-2
Wharton’s jelly
mesenchymal stromal cells
umbilical-cord-derived mesenchymal stromal cells
extracellular vesicles
Online Access:https://www.mdpi.com/2073-4409/12/12/1664

Similar Items

Similar Items